Viewing nowDaidian Tablet 10 mg (Empagliflozin)
Empagliflozin 10mg
Tablet · Prescription medication
HuTex Pharmaceuticals Co., Ltd.

MFDS item code 202102107 · Approved 2021.03.05 · Insurance code 649105200
Improvement of glycemic control in adults with type 2 diabetes
This medication is used in conjunction with diet and exercise to help control blood sugar levels in adult patients with type 2 diabetes. It can be administered as monotherapy, and if adequate blood sugar control is difficult at the initial treatment stage, it can be combined with metformin. Additionally, this drug can be added to enhance treatment efficacy in patients who struggle to control blood sugar with metformin alone or other combination therapies. It may be used with various combination therapies such as insulin therapy or DPP-4 inhibitors. It is particularly important for patients with type 2 diabetes who have cardiovascular disease to consult a specialist regarding additional precautions. This medication helps improve blood sugar control and aids in diabetes management.
The recommended dose of this medication is 10 mg once daily, either as monotherapy or as add-on combination therapy with other blood glucose-lowering agents, such as insulin. If 10 mg of this medication is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, Section 3. Adverse Reactions). This medication may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take double the dose in one day. Special populations • Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medication should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medication well but have a persistently estimated glomerular filtration rate below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose of this medication should be adjusted to or maintained at 10 mg once daily. This medication should be discontinued if the estimated glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. Do not use this medication in patients with end-stage renal disease (ESRD) or those on dialysis, as efficacy is not expected. • Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medication is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. • Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years and older. Initiation of treatment with this medication is not recommended in patients aged 85 years and older, as clinical experience is limited (see Precautions for Use, Section 4. General Precautions)
This medication should not be used in patients who are allergic to the active ingredient or any of its components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely reduced kidney function, specifically those with a glomerular filtration rate of less than 30 mL/min/1.73m2 or those with end-stage renal disease or those on dialysis should not use this medication. This drug contains lactose, so it should not be given to patients with genetic issues such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. It should be used with caution in patients with mild kidney impairment, and it is recommended not to initiate treatment if the glomerular filtration rate is below 60 mL/min/1.73m2. If kidney function continues to decline and falls below 45 mL/min/1.73m2, this medication should be discontinued. Caution should be exercised in patients with mild heart failure, and it is not recommended for severe heart failure patients. This drug may increase the risk of hypoglycemia when used with insulin or sulfonylureas, so dosage adjustments may be necessary when combined. While taking this medication, be alert for hypoglycemic symptoms, especially when used with insulin or sulfonylureas. Adverse effects such as genital infections, urinary tract infections, and increased urination may occur, so consult a healthcare provider immediately if symptoms arise. There may be a risk of lowered blood pressure or dehydration due to reduced fluid volume, so elderly patients or those taking blood pressure medications should be cautious. Severe metabolic disturbances such as ketoacidosis may occur rarely, so if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing arise, visit a hospital immediately. Pregnant women should avoid taking this medication, and if pregnancy is confirmed, they should discontinue use immediately. Breastfeeding women are also recommended to stop breastfeeding while taking this medication. Children under 18 years old should not use this medication as its safety and efficacy have not been established. No special toxicity has been reported in the case of overdose, but appropriate treatment based on clinical conditions is necessary. This medication should be kept out of reach of children and not transferred to another container as a safety measure. Caution is needed when driving or operating machinery due to the risk of hypoglycemia, especially when taken in conjunction with insulin or sulfonylureas. Patients with diabetes should pay attention to routine foot care, and since serious side effects such as limb amputation have been reported rarely, regular foot checks are advised. If there is pain, soreness, swelling, or fever in the perineal area, it may indicate the possibility of perineal necrosis, so inform a healthcare provider immediately and seek treatment.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 to 30 degrees Celsius.
Pale yellow, biconvex, round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEmpagliflozin 10mg
Tablet · Prescription medication
HuTex Pharmaceuticals Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Korea Prime Pharmaceuticals Co., Ltd.

Empagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Empagliflozin 25mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.